Funding News

The latest funding calls which may be of interest to Impact Science clients

 

NIHR, HS&DR Programme Researcher-Led Workstream – Deadline for Outline Applications, 25th September 2014 1pm 

Remit

The HS&DR programme funds research to improve the quality, effectiveness and accessibility of the NHS, including evaluations of how the NHS might improve delivery of services.

The HS&DR Programme aims to support a range if types of research including evidence synthesis and primary research. This includes large scale studies of national importance to the NHS, with the cost in line with the significance of the problem to be investigated and which are likely to lead to changes in practice that will have a significant impact on a large number of patients.

Eligibility

Researchers in England, Wales and Northern Ireland are eligible to apply for funding from the researcher-led workstream under this programme.

Given the aim of the HS&DR programme, successful projects are likely to involve partnership working between experienced academic teams and those involved in the delivery of services

Grant Value

The HS&DR Programme will fund a range of projects in both size and duration. Value for money will be an important consideration and project costs will be carefully scrutinised and must be well justified. NIHR programmes fund Higher Education Institutions (HEIs) at a maximum of 80% of Full Economic Cost (except for equipment over £50,000). For non-HE Institutions, NHS R&D may fund 100% of costs.

How to Apply

For more information regarding this funding opportunity and information on how to apply, visit http://www.nets.nihr.ac.uk/funding/hsdr-researcher-led

North West Cancer Research (NWCR) Fund – Application Deadline, 1st October 2014 

Remit

Grants are provided by North West Cancer Research to fund cancer research across three main areas: Basic, Translational and Preventative.

Eligibility

The research must be carried out in the North West of England, North or Mid Wales (Cumbria, Lancashire, Merseyside, Cheshire, North Staffordshire, to the west of a line drawn from Appleby to Bolton to Newcastle-Under-Lyme and North and Mid Wales to the north of a line drawn from Newcastle-Under-Lyme through Welshpool, Market Drayton and Machynlleth). Project grants may be provided to support students undertaking research in cancer leading to a higher degree.  At each submission deadline only one application, per applicant named as the primary applicant will be considered.  In addition, one additional application, per applicant named as the co-applicant can also be considered.

Grant Value

Project grants are normally awarded for three years and, are subject to satisfactory review at the end of the first and, final year.  NWCR currently give grants ranging from £750,000 to £1,000,000 a year.

How to Apply

For more information regarding this funding opportunity and information on how to apply, visit http://www.nwcr.org/Research-1368.html

NIHR, Efficacy and Mechanism Evaluation Programme Commissioned Calls – Application Deadline, 7th October 2014 1pm 

Remit

The remit of the EME Programme includes clinical trials and evaluative studies of novel and repurposed interventions.  The term intervention is meant in the broadest sense and includes any method used to promote health, prevent and treat disease and improve rehabilitation or long-term care. The EME programme is looking to support studies in patients which seek to:

  • evaluate clinical efficacy of interventions (where proof of concept in humans has already been achieved);
  • add significantly to our understanding of biological or behavioural mechanisms and processes;
  • explore new scientific or clinical principles;
  • include the development or testing of new methodologies.

Commissioned Calls

  • Mechanisms of action of health interventions
  • Wound healing
  • Bowel control and faecal incontinence in adults
  • Renal failure resulting from intrinsic renal diseases
  • Pituitary and/or adrenal disorders and related diseases

Award Value

There are no fixed limits on the duration of projects and proposals should be tailored to fully address the questions posed. Applicants should be aware that they are competing for limited funds and proposals should represent good value for money. All funding requested should be clearly justified, but there is no upper limit. Current project portfolio – http://www.nets.nihr.ac.uk/projects?collection=netscc&meta_P_sand=Project.

Eligibility

Researchers in England, Northern Ireland, Scotland and Wales are eligible to apply for funding under this Programme.

The EME Programme welcomes applications proposing joint funding arrangements or collaboration with other organisations.

How to Apply

For more information regarding this funding opportunity and information on how to apply, visit http://www.nets.nihr.ac.uk/funding/eme-commissioned

British Society for Paediatric Endocrinology and Diabetes (BSPED), Research Awards – Application Deadline, 30th September 2014

Remit 

Each year the BSPED offers a limited number of small project grants that are intended to promote and support academic research by its members. The grants are intended to support endocrinologists and trainees in a number of ways. Specifically they are meant to provide:

  • the resources to obtain preliminary data before applying for other external funding
  • the funding required to con duct a small project
  • the funding required for a specific piece of equipment
  • the resources to complete a project

Eligibility

Applications will only be considered if submitted by a member of the BSPED who has been a member for at least one year by the date of submission deadline. Other scientists and clinicians who are in-training may apply if they hold a minimum of six months’ membership or if their research team includes a member of at least 1 year standing. The applicant may be an academic or academic-related staff member, a paediatric endocrinologist, paediatrician with an interest in endocrinology or a paediatric endocrine trainee.

Award Value

This year there will be two BSPED Research Awards of up to a maximum of £15,000 each

More Information

For more information and details of how to apply visit – http://www.bsped.org.uk/awards/awards_research.html

NIHR, Health Technology Assessment (HTA) Programme, Primary Research – Outline Application Deadline, 16th September 2014

Remit

The aim of the HTA Programme is to ensure that high quality research information on the effectiveness, costs and broader impact of health technology is produced in the most efficient way for those who use, manage, provide care in or develop policy for the NHS. Topics for research identified and prioritised to meet the needs of the NHS. Health technology assessment forms a substantial portfolio of work within the National Institute for Health Research and each year about fifty new studies are commissioned to help answer questions of direct importance to the NHS. The studies include both primary research and evidence synthesis.

Topics

14/162 – A clinical decision aid to inform the management of lower urinary tract symptoms in men in primary care

14/163 – Specialist intensive inpatient rehabilitation for new lower limb amputees

14/171 – Extended rehabilitation for older frail people after acute illness or injury

14/173 – Methylphenidate and dexamethasone in cancer-related fatigue

Eligibility

Anyone who considers that they can carry out high-quality research is likely to be eligible. If you have any concerns regarding your eligibility to apply NIHR advise that you contact them before completing an application. If you have any concerns regarding your eligibility to apply we advise that you contact NIHR before completing an application. The HTA programme welcome applications which are within the programmes’ remits from all sectors. Applicants from non-clinical or non-academic sectors are strongly advised to consider collaborating with the relevant sectors or organisations to demonstrate they have the full breadth of expertise required to carry out their proposed research within their applications to the HTA programme. Applicants should always check individual call specification documents, or commissioning brief, for any additional eligibility requirements.

More Information

For more information and details of how to apply visit – http://www.nets.nihr.ac.uk/funding/hta-commissioned

The Royal Society, The Brian Mercer Feasibility Award – Scheme Open to Applications (rolling)

Remit

The Brian Mercer Feasibility Awards aim to provide initial support to test the technical and economical feasibility of commercialising an aspect of their scientific research, possibly in conjunction with a

third party.

The Mercer Feasibility Awards are intended to help academics take the steps necessary to demonstrate that their concept has a high potential for commercial success. The project will have demonstrated successful past research and will now be entering the development stage. The proposal should address the technical viability to show that it is economic and competitive. It must also be shown that there is a commercial need of a sufficient magnitude to attract later finance, if the study is successful. Third party financial and in-kind assistance will always be helpful in making the case for Mercer Feasibility Award support

Subjects covered: The general areas of electrotechnology and biomedical sciences.

Eligibility

The Award is open to applicants of any nationality who have a PhD (or are of equivalent standing in their profession), who hold a substantive post in a UK university of not-for-profit research organisation and who will be in post for at least the duration of the projects. Applicants may make only one application per round. Applications from individuals or groups who already have established contacts with industrial or commercial collaborators are particularly encouraged.

Award Value

The scheme provides an award of up to £30,000 (including VAT where applicable). Awards are not expected to exceed 12 months in duration.

More Information

For more information and details of how to apply visit – https://royalsociety.org/grants/schemes/brian-mercer-feasibility/

NIHR, Health Service and Delivery Research (HS&DR) Programme – Commissioned Calls – Outline Proposal Deadline 1pm 11th September 2014

Remit

The HS&DR programme funds research to improve the quality, effectiveness and accessibility of the NHS, including evaluations of how the NHS might improve delivery of services.

The HS&DR Programme aims to support a range if types of research including evidence synthesis and primary research. This includes large scale studies of national importance to the NHS, with the cost in line with the significance of the problem to be investgated and which are likely to lead to changes in practice that will have a significant impact on a large number of patients.

Commissioned Calls:

  • 14/155 New research on leadership development in health and care

At a time of increasing demands and reduced resources, there is a greater need for effective leadership and management of health and care services. But not enough is known about what works and how best to support and nurture good leadership. The NHS has invested substantive resources in new leadership programmes and there are opportunities for research to identify the most effective and cost-effective forms of training and development, as well as theory-driven studies to understand models of leadership in organisations.

  • 14/156 New research on use and usefulness of the patient experience data

Although this country has led the way with a national patient survey programme in some form since 2001, this is a relatively new field of activity for research in this country. There is still uncertainty about how to collect the data in a timely way from different kinds of patients, present it in a meaningful way which stimulates action and how to align national requirements with local needs. There is debate about the best level in an organisation to share the data (ward, directorate, locality or community team) and how best to do this to improve performance, reflect on practice or identify system weaknesses. Evidence suggests that while many provider organisations are now capturing patient experience data of different kinds, less effort has been spent to date in using this information to improve the quality of services. Overall, there is little UK-based research on how best to make use of patient experience data or what organisations can do to ensure that patient feedback shapes services and care.

Eligibility

Anyone who considers that they can carry out high-quality research is likely to be eligible. If you have any concerns regarding your eligibility to apply we advise that you contact NIHR before completing an application.

Applicants are strongly advised to consider establishing partnerships with other relevant sectors or organisations to demonstrate they have the full breadth of expertise to carry out their proposed research in their applications.

How to Apply

For more information regarding this funding opportunity and information on how to apply, visit http://www.nets.nihr.ac.uk/funding/hsdr-commissioned

MRC, Public Health Intervention Development Scheme (PHIND) – 4pm 12th September 2014

Remit

PHIND is a rapid response funding scheme aimed at improving the initial evidence on which development and evaluation of public health interventions are based. Studies should address an important UK or global public health issue and offer an innovative approach to intervention development or applying an existing intervention in a new setting. Interventions should be for primary prevention in a general, high risk or vulnerable population. Interventions treating clinical conditions or improving health services delivery are ineligible for funding.

Award Value

Applicants can apply for up to £150K for a maximum of 18 months. Funds may be requested to support costs attributable to the study including investigator and research staff time, consumables, equipment and travel.

Eligibility

The usual MRC funding and eligibility rules apply. Please see the application handbook (http://www.mrc.ac.uk/documents/pdf/handbook-for-applicants-and-grant-holders/and the Research Councils UK website (http://www.rcuk.ac.uk/website for information regarding eligibility.

How to Apply

For more information regarding this funding opportunity and information on how to apply, visit http://www.mrc.ac.uk/funding/browse/public-health-intervention-development-scheme-phind/

DoH/Wellcome Trust, Health Innovation Challenge (HIC) Awards – Preliminary Applications Deadline 15th September 2014

Remit

The Health Innovation Challenge Fund is positioned as a translational funding scheme to accelerate the clinical application of projects that are well advanced along the development pathway.

Its objectives are to:

  • Stimulate the development and uptake of innovative products, technologies and interventions for the benefit of patients in the NHS and other healthcare systems;
  • Support UK-led projects, which target unmet, or poorly met, healthcare needs.
  • Provide translational funding for projects that have demonstrated ‘proof-of-principle’ and have the potential for early clinical use or adoption;
  • Take the product, technology or intervention to the stage at which it is sufficiently validated and developed to be attractive to follow-on funders or investors;
  • Encourage the collaboration of companies, academia and clinicians to better confront today’s healthcare challenges.

Special areas of interest:

  • Surgical technologies
  • Innovative diagnostics
  • Trauma and critical care medicine
  • Informatics to assist clinical decision making
  • Repurposing of technologies and medicines
  • Biological therapeutics

Eligibility

The lead organisation must be UK-based and carry out R&D in the UK. Overseas collaborators are permitted. The following types of organisation are eligible for funding:

  • Publicly listed or privately owned companies;
  • SMEs (including start-up or ‘spin-out’ companies);
  • NHS organisations (including NHS Trusts and NHS Foundation Trusts), and equivalent UK authorities;
  • Universities, research institutes and not-for-profit organisations.

A collaboration between two or more of the above is eligible and is actively encouraged where it strengthens the overall proposal. Wherever there is a commercial partner in such a collaboration that will ultimately be responsible for the development and sale of the end product then that party should assume the role of lead applicant

How to Apply

For more information regarding this funding opportunity and information on how to apply, visit http://www.wellcome.ac.uk/Funding/Innovations/Awards/Health-Innovation-Challenge-Fund/index.htm

MRC, Partnership Grants – Outline Case Deadline 30th July 2014

Remit

The Partnership grant aims to provide core funds for one to five years for managed consortia and partnerships and for supporting more diverse groupings of researchers, who may lack the scale, longevity, or organisation expected of an MRC centre. Support can be requested for between one and five years.

 The Partnership Grant should add value to high-quality scientific programmes that are already supported by grants from the MRC and other funders. The funding for new research projects which may arise from the Partnership should be pursued through MRC Programme and Research Grants and training awards, coupled with other schemes and non-MRC funding. Therefore, the Partnership Grant scheme is NOT designed to fund research that can be funded by our standard schemes

Deadlines

MRC has four Research Boards which award grants in different scientific areas and has different application deadline dates. Applicants must contact the Programme Manager of the relevant MRC research Board to discuss the grant at least 6 weeks before submitting – this is a mandatory step.

When contacting the Programme Manager MRC ask that applicants send the following by email:

  • Case: max. 2 pages
  • Resources: please provide a high level indication of the likely cost to the MRC
  • CV for lead and co-investigators: max. 2 pages, plus 1 page for key publications

Molecular and Cellular Medicine – 4PM 10th September 2014

Infection and Immunity – 4PM 16th September 2014

Populations and Systems – 4PM 30th September 2014

Neurosciences and Mental Health – 4PM 1st October 2014

Grant Award

Support can be requested for between one and five years. The Partnership Grant should add value to high-quality scientific programmes that are already supported by grants from the MRC and other funders. Details of research funded my MRC, including the amount awarded can be found here.

Eligibility

Any UK based researcher who can demonstrate that they will direct the proposed partnership activities and manage the funding on behalf of the MRC to ensure that the objectives are fully delivered. This scheme is not open to MRC Institutes and Units, but is open to those based at a University Unit. However, MRC Institutes and Units can apply as co-applicants on any grant. The lead PI must be based at the lead organisation & their research organisation must be able to apply in response mode.

More Information and How to Apply

MRC Partnership Grant webpage – http://www.mrc.ac.uk/funding/how-we-fund-research/partnership-grant/

Research Board deadlines – http://www.mrc.ac.uk/funding/deadlines/research-board-submission-deadlines/

Highlight Notices – http://www.mrc.ac.uk/funding/how-we-fund-research/highlight-notices/

MRC, Research Grants – Application Deadlines Sept/Oct 2014

Remit

MRC research grants are suitable for focused research projects that may be short- or long-term in nature. In addition, they can be used to support method development or development and continuation of research facilities and may involve more than one research group or institution. A research grant can be awarded for any period of up to five years, but those of two years or less are for proof of principle or pilot work only. Applications seeking support of greater than three years should provide a clear justification as to why a longer timescale is needed, for example due to specific research deliverables, or the need for prolonged data collection or follow-up.

Deadlines

Molecular and Cellular Medicine – 4PM 10th September 2014

Infection and Immunity – 4PM 16th September 2014

Populations and Systems – 4PM 30th September 2014

Neurosciences and Mental Health – 4PM 1st October 2014

Grant Award

The budget for research grant awards will not typically exceed £1 million.

Eligibility 

Any UK-based researcher who can demonstrate that they will direct the proposed research and be actively engaged in carrying it through.The minimum academic qualification required is a graduate degree, although usually a PhD is required. Less experienced researchers should apply in collaboration with a more senior colleague. The applicant(s) must demonstrate that they will direct the proposed research and be actively engaged in the work. Applications can include an industry partner(s).

More Information and How to Apply

MRC Research Grant webpage – http://www.mrc.ac.uk/funding/how-we-fund-research/research-grant/

Research Board deadlines – http://www.mrc.ac.uk/funding/deadlines/research-board-submission-deadlines/

Highlight Notices – http://www.mrc.ac.uk/funding/how-we-fund-research/highlight-notices/

MRC, Programme Grants – Outline Case Deadline 30th July 2014

Remit

Programme grants provide larger, longer term (five years) and renewable programme funding. They aim to help the medical science community to ‘think bigger’. A programme is defined as a coordinated and coherent group of related projects, which may be developed to address an inter-related set of questions across a broad scientific area. The expectation is that not all the questions will necessarily be answered within the tenure of the award. Parts of the programme may well be a continuation of current activity; however, other elements should be innovative and ambitious.

Deadlines

MRC has four Research Boards which award grants in different scientific areas and has different application deadline dates. Applicants must contact the Programme Manager of the relevant MRC research Board to discuss the grant at least 6 weeks before submitting – this is a mandatory step.

When contacting the Programme Manager MRC ask that applicants send the following by email:

  • Case: max. 2 pages
  • Resources: please provide a high level indication of the likely cost to the MRC
  • CV for lead and co-investigators: max. 2 pages, plus 1 page for key publications

Molecular and Cellular Medicine – 4PM 10th September 2014

Infection and Immunity – 4PM 16th September 2014

Populations and Systems – 4PM 30th September 2014

Neurosciences and Mental Health – 4PM 1st October 2014

Grant Award

Details of research funded my MRC, including the amount awarded can be found here

Eligibility

Any UK-based researcher who can demonstrate that they will direct the proposed research and be actively engaged in carrying it through can apply. The minimum academic qualification required is a graduate degree, although usually a PhD is expected. For programme grants the Principal Investigator should have a substantial record of successfully securing research funding and delivering high quality research. Programme grants will usually (though not always) be based within an academic institution which has the variety of expertise and disciplines to undertake the programme. MRC Units and University Units are not eligible to apply.

More Information and How to Apply

MRC Programme Grant webpage – http://www.mrc.ac.uk/funding/how-we-fund-research/programme-grant/

Research Board deadlines – http://www.mrc.ac.uk/funding/deadlines/research-board-submission-deadlines/

Highlight Notices – http://www.mrc.ac.uk/funding/how-we-fund-research/highlight-notices/

NIHR, Efficacy and Mechanism Evaluation (EME) Programme Commissioned Call – Outline Application Deadline 1pm 8th September 2014.

Topic – Major Trauma
Proposals are invited for research into the efficacy of interventions for the diagnosis and management of complex injuries following major trauma. The EME Programme is particularly interested in therapeutic interventions targeted at managing the systemic physiological and haematological responses to injury. Proposals may include the early assessment, immediate management or use of interventions within the first 72 hours of the major trauma.

Commissioning brief – http://www.nets.nihr.ac.uk/__data/assets/pdf_file/0006/118833/MRC-trauma-brief.pdf

Remit
The remit of the EME Programme includes clinical trials and evaluative studies of novel and repurposed interventions. The term intervention is meant in the broadest sense and includes any method used to promote health, prevent and treat disease and improve rehabilitation or long-term care. The EME programme is looking to support studies in patients which seek to:

  • evaluate clinical efficacy of interventions (where proof of concept in humans has already been achieved);
  • add significantly to our understanding of biological or behavioural mechanisms and processes;
  • explore new scientific or clinical principles;
  • include the development or testing of new methodologies.

Award Value
There are no fixed limits on the duration of projects and proposals should be tailored to fully address the questions posed. Applicants should be aware that they are competing for limited funds and proposals should represent good value for money. All funding requested should be clearly justified, but there is no upper limit. Current project portfolio – http://www.nets.nihr.ac.uk/projects?collection=netscc&meta_P_sand=Project.

Eligibility
Researchers in England, Northern Ireland, Scotland and Wales are eligible to apply for funding under this Programme.
The EME Programme welcomes applications proposing joint funding arrangements or collaboration with other organisations.

More Information and How to Apply
Application Guidance – http://www.nets.nihr.ac.uk/__data/assets/pdf_file/0005/118832/Outline_GuidanceNotes_MajorTrauma_October_2014.pdf
Webpage – http://www.nets.nihr.ac.uk/funding/eme-commissioned

NIHR, Health Technology Assessment (HTA) Programme (Researcher-Led Evidence Synthesis) – Full Application Deadline, 1PM 8th September 2014.

Remit
The NIHR HTA Programme supports research that is immediately useful to patients, clinical practice, and policy or decision makers.
HTA research is undertaken when evidence exists to show that a technology can be effective. The purpose of an HTA study is to establish the clinical and cost-effectiveness for the NHS in comparison with the current best alternative(s). A study may also investigate uncertainty around a technology’s place in the existing care pathway.

“Technologies” in this context mean any method used to promote health; prevent and treat disease; and improve rehabilitation or long-term care. They are not confined to new drugs and include any intervention used in the treatment, prevention or diagnosis of disease. The HTA programme is interested in receiving proposals addressing any health problem in areas not otherwise well covered in the portfolio (please see http://www.nets.nihr.ac.uk/faqs).

Award Value
There are no fixed limits on the duration of projects and proposals should be tailored to fully address the questions posed. Applicants should be aware that they are competing for limited funds and proposals should represent good value for money. All funding requested should be clearly justified, but there is no upper limit. Current project portfolio – http://www.nets.nihr.ac.uk/projects?collection=netscc&meta_P_sand=Project.

Eligibility
Subject to meeting programme-specific eligibility criteria, anyone who considers that they can carry out high-quality research is likely to be eligible. If you have any concerns regarding your eligibility to apply NIHR advise that you contact them before completing an application. Applications are welcome which are within the programmes’ remits from all sectors. Applicants are strongly advised to consider establishing partnerships with other relevant sectors or organisations to demonstrate they have the full breadth of expertise to carry out their proposed research in their applications. Applicants should always check individual call specification documents for any additional eligibility requirements.

More Information and How to Apply
Call webpage – http://www.nets.nihr.ac.uk/funding/hta-researcher-led
Call specification – http://www.nets.nihr.ac.uk/__data/assets/pdf_file/0003/118146/Sep-2014-cut-off-CET-Spec-Doc.pdf
Application guidance – http://www.nets.nihr.ac.uk/__data/assets/pdf_file/0005/79664/FullGuidanceNotesSAF-V1_12.pdf

NIHR, Health Technology Assessment (HTA) Programme (Researcher-Led) – Outline Application Deadline, 1PM 8th September 2014.

Remit
The NIHR HTA Programme supports research that is immediately useful to patients, clinical practice, and policy or decision makers.
HTA research is undertaken when evidence exists to show that a technology can be effective. The purpose of an HTA study is to establish the clinical and cost-effectiveness for the NHS in comparison with the current best alternative(s). A study may also investigate uncertainty around a technology’s place in the existing care pathway.
“Technologies” in this context mean any method used to promote health; prevent and treat disease; and improve rehabilitation or long-term care. They are not confined to new drugs and include any intervention used in the treatment, prevention or diagnosis of disease. The HTA programme is interested in receiving proposals addressing any health problem in areas not otherwise well covered in the portfolio (please see http://www.nets.nihr.ac.uk/faqs).

Award Value
There are no fixed limits on the duration of projects and proposals should be tailored to fully address the questions posed. Applicants should be aware that they are competing for limited funds and proposals should represent good value for money. All funding requested should be clearly justified, but there is no upper limit. Current project portfolio – http://www.nets.nihr.ac.uk/projects?collection=netscc&meta_P_sand=Project.

Eligibility
Subject to meeting programme-specific eligibility criteria, anyone who considers that they can carry out high-quality research is likely to be eligible. If you have any concerns regarding your eligibility to apply NIHR advise that you contact them before completing an application. Applications are welcome which are within the programmes’ remits from all sectors. Applicants are strongly advised to consider establishing partnerships with other relevant sectors or organisations to demonstrate they have the full breadth of expertise to carry out their proposed research in their applications. Applicants should always check individual call specification documents for any additional eligibility requirements.

More Information and How to Apply
Call webpage – http://www.nets.nihr.ac.uk/funding/hta-researcher-led
Call specification – http://www.nets.nihr.ac.uk/__data/assets/pdf_file/0003/118146/Sep-2014-cut-off-CET-Spec-Doc.pdf
Application guidance – http://www.nets.nihr.ac.uk/__data/assets/pdf_file/0005/67685/OutlineGuidanceNotesSAF-V2_6.pdf

NIHR, Health Technology Assessment (HTA) Programme Commissioned Calls – Outline Application Deadline, 14th August 2014

Remit

The aim of the HTA Programme is to ensure that high quality research information on the effectiveness, costs and broader impact of health technology is produced in the most efficient way for those who use, manage, provide care in or develop policy for the NHS. Topics for research identified and prioritised to meet the needs of the NHS. Health technology assessment forms a substantial portfolio of work within the National Institute for Health Research and each year about fifty new studies are commissioned to help answer questions of direct importance to the NHS. The studies include both primary research and evidence synthesis.

Primary Research Commissioned Call

Covered versus uncovered self-expanding metal bowel stents – Are covered or uncovered self-expanding metal stents more clinically effective for patients requiring a colorectal stent? A recent systematic review concluded that tumour ingrowth was more common with uncovered stents, but that late migration occurred more frequently with covered stents, and expulsion causes significant morbidity. However, the authors noted that there was potential for publication bias and that the evidence was very limited as there has only been one small, single centre RCT to date. Consequently, the authors recommended definitive primary research to compare covered and uncovered stents in order to assess their clinical and cost-effectiveness. Commissioning brief – http://www.nets.nihr.ac.uk/__data/assets/pdf_file/0015/112371/14_28cb.pdf

Award Value

None specified but generally range from £100,000 to £2 million.

Eligibility

Anyone who considers that they can carry out high-quality research is likely to be eligible. If you have any concerns regarding your eligibility to apply NIHR advise that you contact them before completing an application.Applicants are strongly advised to consider establishing partnerships with other relevant sectors or organisations to demonstrate they have the full breadth of expertise to carry out their proposed research in their applications to the PHR programmes. Applicants should always check individual call specification documents for any additional eligibility requirements.

More Information and How to Apply

HTA Webpage – http://www.nets.nihr.ac.uk/funding/hta-commissioned
Guidance for Outline Applications – http://www.nets.nihr.ac.uk/__data/assets/pdf_file/0005/67685/OutlineGuidanceNotesSAF-V2_6.pdf